Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

nice tom...gnus bounce

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JusDePomme Member Profile
 
Followed By 338
Posts 44,877
Boards Moderated 5
Alias Born 12/18/03
160x600 placeholder
Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients GlobeNewswire Inc. - 10/27/2021 2:26:27 PM
Sorrento: Covid-19 Tests Could Generate Significant Revenue, Says Analyst TipRanks - 10/26/2021 6:11:23 PM
Sorrento Announces That COVISTIX™ (COVID-19 Virus Rapid Antigen Detection Test) Has Received a CE Mark and Registration of the Device GlobeNewswire Inc. - 10/20/2021 1:37:01 PM
Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple solid tumors GlobeNewswire Inc. - 10/13/2021 9:30:00 AM
FDA Authorizes Sorrento Phase 2 Trial of Epidural Resiniferatoxin for the Orphan Indication of Control of Intractable Cancer Pain GlobeNewswire Inc. - 10/13/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2021 9:01:56 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/29/2021 2:36:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2021 5:38:12 PM
CORRECTION - Sorrento Therapeutics, Inc. GlobeNewswire Inc. - 9/28/2021 2:23:52 PM
Sorrento to Participate in the Benzinga Healthcare Small Cap Conference on September 30th GlobeNewswire Inc. - 9/28/2021 12:23:08 PM
Dr. Henry Ji, Sorrento Chairman and CEO, to Participate in the Virtual Cantor Global Healthcare Conference on September 29th, 2021 GlobeNewswire Inc. - 9/27/2021 1:13:08 PM
Sorrento Reports Positive Results for COVISTIX COVID-19 Detection TipRanks - 9/20/2021 7:00:16 AM
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test GlobeNewswire Inc. - 9/19/2021 2:58:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 5:01:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 1:37:13 PM
Dr. Henry Ji, Sorrento Chairman and CEO, to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 GlobeNewswire Inc. - 9/13/2021 9:00:00 AM
Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in ICU Patients GlobeNewswire Inc. - 9/2/2021 11:34:20 AM
Sorrento Exercises Exclusive Option Agreement With Texas A&M University for MPRO Inhibitors Against Sars-Cov-2 and all Variants of Concern GlobeNewswire Inc. - 8/26/2021 3:42:09 PM
Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device GlobeNewswire Inc. - 8/26/2021 12:28:06 PM
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University GlobeNewswire Inc. - 8/24/2021 10:44:48 AM
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel GlobeNewswire Inc. - 8/23/2021 3:52:24 PM
Will Sorrento’s Promising COVID-19 Vaccine Results Boost Stock? TipRanks - 8/20/2021 11:02:54 AM
Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of Concern GlobeNewswire Inc. - 8/19/2021 4:21:34 PM
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary Announces Expansion of Ztlido® Managed Care Coverage for Additional 33 Million Lives GlobeNewswire Inc. - 8/19/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/11/2021 9:02:25 AM
JusDePomme   Monday, 05/18/20 10:14:28 AM
Re: tomj1 post# 2756
Post # of 11787 
nice tom...gnus bounce

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences